BioCentury | Dec 20, 2019

An inhibitor of viral latency for imaging, treating EBV-associated cancers Proc. Natl. Acad. Sci. USA ; published online Dec. 10, 2019 doi:10.1073/pnas.1915372116 CONTACT: Hong Lok...
BioCentury | Jul 18, 2016
Company News

Citius Pharmaceuticals sales and marketing update

...longer meets our core strategic objectives.” The company will focus on developing Mino-Lok and Hydro-Lido. Mino-Lok...
BioCentury | Dec 17, 2015
Translation in Brief

Old PKIS, new probes

...compounds whose off-target effects include inhibition of understudied kinases, such as lymphocyte-oriented kinase ( LOK ; STK10...
BioCentury | Nov 17, 1997
Company News

Penederm, Allergan deal

...Allergan's Allergan-Lok Produtos Pharmaceuticos Ltda. subsidiary (Buenos Aires, Argentina) received an exclusive license to manufacture and...
Items per page:
1 - 4 of 4